ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1617

Influence of Disease Activity in the Physical Activity of Psoriatic Arthritis Patients

M. Vanesa Hernandez-Hernandez1, Hiurma Sanchez-Perez2, Esmeralda Delgado-Frías1, Iván Ferraz-Amaro3 and Federico Díaz-González4, 1Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, 2Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, 3Rheumatology Division, Hospital Insular de Gran Canaria, La Laguna, Spain, 4University of La Laguna, Hospital Universitario de Canarias, La Laguna, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity, exercise, Physical function and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: It is generally assumed that patients with chronic arthritis conditions tend to exercise less than what is currently recommended. Although several evidences support this contention in rheumatoid arthritis patients, there is little data on the level of daily physical activity (PA) in psoriatic arthritis (PsA) patients vs. healthy controls, using objective procedures, such as accelerometry. Moreover, there is currently no evidence that decisively answers an important question concerning PA vis-à-vis PsA: Does disease activity influence PA in PsA patients?

The purposes of this study were to compare PA in a group of PsA patients versus healthy controls through both objective (triaxial accelerometry) and subjective (International Physical Activity Questionnaire- IPAQ) methods, and to explore the impact of disease levels on PA in these patients. We also sought to determine the potential role of PA assessment as a measure of PsA disease activity.

Methods: A group of 53 PsA patients and 36 age- and sex-matched healthy controls were included in this cross-sectional study. PA was assessed by accelerometry and with iPAQ in both groups. We performed multiple regression analysis not only to compare PA between groups, but also to explore the relationship between PsA features, including disease activity (assessed by DAS28-ESR, DAS28-PCR and DAPSA) and PA. In a randomized group of 36 PsA patients a test/re-test study was carried out 6 month after the first evaluation in order to determine the correlation between variation in disease activity and PA.

Results: The number of minutes of moderate and vigorous activity (MVPA)/day, as evaluated by accelerometry and adjusted for sex, age work activity was similar in PsA patients and in healthy controls (40 ± 29 vs 33 ± 15 min/day, p=0.2). In PsA patients, accelerometry and IPAQ demonstrated concordance to a moderate degree. When PA between the two visits of PsA patients was compared, a significant differences in minutes of MVPA was found (40 ± 29 vs 30 ± 22 min/day, p=0.035). Interestingly, variations in PA, as measured by accelerometry, inversely correlated with RA disease activity by DAS28-PCR (r=-0.37, p= 0.04) and DAPSA (r=-0.43, P = 0.01). When this analysis was done assessing disease activity by DAS28-ESR, a similar, but not significant tendency was observed (r=-0.34, p= 0.07).

Conclusion: In PsA patients, accelerometry is a reliable technique to evaluate PA. This study not only showed that PsA patients spend similar time doing MVPA than healthy controls, but also PA, as assessed by accelerometry, was sensitive to any changes in disease activity.


Disclosure: M. V. Hernandez-Hernandez, None; H. Sanchez-Perez, None; E. Delgado-Frías, None; I. Ferraz-Amaro, None; F. Díaz-González, None.

To cite this abstract in AMA style:

Hernandez-Hernandez MV, Sanchez-Perez H, Delgado-Frías E, Ferraz-Amaro I, Díaz-González F. Influence of Disease Activity in the Physical Activity of Psoriatic Arthritis Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/influence-of-disease-activity-in-the-physical-activity-of-psoriatic-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-disease-activity-in-the-physical-activity-of-psoriatic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology